Apimeds names Eric Sherb as CFO after Erick Frim resigns
The company disclosed on a Form 8-K that Frim stepped down as interim finance chief and Sherb will take over the role starting October 1, 2026.
SEC filing
Latest
3 stories
Today
Friday, August 28
GlucoTrack files financials for merged Lokahi Therapeutics, flags going concern doubt
An 8-K/A filed August 28, 2026 shows Lokahi had $53,186 in cash at June 30, 2026 and an accumulated deficit of $8.8 million, with auditors citing substantial doubt about its ability to continue.
SEC filing
Friday, August 21
Apimeds acquires Korean Apitox rights from FreeT in August 2026 assignment deal
The agreement transfers FreeT's stake in Apitox, including a domestic Korean market claim and royalty rights on U.S. and overseas proceeds.
SEC filing